No. Position Ref Alt Gene Symbol Functional Effect MITOMAP Disease Clinical Information MITOMAP Disease Clinical Status References Details
1 73 A G . . . . No References Variant Details
2 263 A G . . . . No References Variant Details
3 302 - C . . . . No References Variant Details
4 310 - C . . . . No References Variant Details
5 349 C T . . . . No References Variant Details
6 489 T C . . . . No References Variant Details
7 513 G T . . . . No References Variant Details
8 750 A G . . . . No References Variant Details
9 785 C A . . . . No References Variant Details
10 1191 C A . . . . No References Variant Details
11 1269 T C . . . . No References Variant Details
12 1428 G A . . . . No References Variant Details
13 1438 A G . . . . No References Variant Details
14 1584 A G . . . . No References Variant Details
15 1872 T C . . . . No References Variant Details
16 2132 A G . . . . No References Variant Details
17 2183 C A . . . . No References Variant Details
18 2219 C A . . . . No References Variant Details
19 2477 G T . . . . No References Variant Details
20 2538 C A . . . . No References Variant Details
21 2702 G A . . . . No References Variant Details
22 2706 A G . . . . No References Variant Details
23 3243 A G . . . . No References Variant Details
24 3279 C G . . . . No References Variant Details
25 3533 C G MT-ND1 missense . . No References Variant Details
26 4272 T A . . . . No References Variant Details
27 4307 A C . . . . No References Variant Details
28 4769 A G . . . . No References Variant Details
29 4920 G C MT-ND2 missense . . No References Variant Details
30 5153 A G . . . . No References Variant Details
31 5217 T C MT-ND2 missense . . No References Variant Details
32 5295 C A MT-ND2 missense . . No References Variant Details
33 5297 C T . . . . No References Variant Details
34 6117 C G MT-CO1 missense . . No References Variant Details
35 6169 C T MT-CO1 missense . . No References Variant Details
36 6233 A G . . . . No References Variant Details
37 6541 G A MT-CO1 missense . . No References Variant Details
38 7028 C T . . . . No References Variant Details
39 7046 A G . . . . No References Variant Details
40 7247 C A . . . . No References Variant Details
41 7257 A G MT-CO1 missense . . No References Variant Details
42 7342 G A MT-CO1 missense . . No References Variant Details
43 7370 C T . . . . No References Variant Details
44 8700 A G . . . . No References Variant Details
45 8701 A G MT-ATP6 missense . . References (102) Variant Details
46 8854 G A MT-ATP6 missense . . References (3) Variant Details
47 8860 A G MT-ATP6 missense . . References (124) Variant Details
48 9024 A T . . . . No References Variant Details
49 9103 T A MT-ATP6 missense . . No References Variant Details
50 9144 C A . . . . No References Variant Details
51 9345 C T . . . . No References Variant Details
52 9540 T C . . . . No References Variant Details
53 10398 A G MT-ND3 missense PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy Reported; lineage L & M marker, also hg IJK References (221) Variant Details
54 10400 C T . . . . No References Variant Details
55 10873 T C . . . . No References Variant Details
56 11151 C T MT-ND4 missense . . References (19) Variant Details
57 11455 C A . . . . No References Variant Details
58 11562 G T MT-ND4 missense . . No References Variant Details
59 11719 G A . . . . No References Variant Details
60 11852 G A MT-ND4 missense . . No References Variant Details
61 12530 A G MT-ND5 missense . . References (1) Variant Details
62 12705 C T . . . . No References Variant Details
63 12753 A G . . . . No References Variant Details
64 12764 G A MT-ND5 missense . . No References Variant Details
65 12797 T A MT-ND5 missense . . No References Variant Details
66 12997 G T MT-ND5 missense . . No References Variant Details
67 13042 G T MT-ND5 missense . . No References Variant Details
68 13433 T C MT-ND5 missense . . No References Variant Details
69 13615 A G MT-ND5 missense LHON Reported References (1) Variant Details
70 13787 T C MT-ND5 missense . . No References Variant Details
71 13860 C A . . . . No References Variant Details
72 14037 A G . . . . No References Variant Details
73 14233 A G . . . . No References Variant Details
74 14766 C T MT-CYB missense . . References (113) Variant Details
75 14783 T C . . . . No References Variant Details
76 15002 G T MT-CYB missense . . No References Variant Details
77 15008 T C MT-CYB missense . . No References Variant Details
78 15024 G A MT-CYB missense Possible DEAF modifier Reported References (3) Variant Details
79 15043 G A . . . . No References Variant Details
80 15301 G A . . . . No References Variant Details
81 15315 C T MT-CYB missense . . References (2) Variant Details
82 15319 C A . . . . No References Variant Details
83 15326 A G MT-CYB missense . . References (116) Variant Details
84 15346 G T MT-CYB missense . . No References Variant Details
85 15588 T C MT-CYB missense . . No References Variant Details
86 15591 G A MT-CYB missense . . No References Variant Details
87 15644 A G MT-CYB missense . . References (2) Variant Details
88 15776 A G MT-CYB missense . . References (2) Variant Details
89 15804 T C MT-CYB missense Fibromyalgia Reported References (5) Variant Details
90 15820 C T . . . . No References Variant Details
91 15932 T C . . . . No References Variant Details
92 16016 A G . . . . No References Variant Details
93 16108 C A . . . . No References Variant Details
94 16127 A G . . . . No References Variant Details
95 16162 A - . . . . No References Variant Details
96 16214 C T . . . . No References Variant Details
97 16218 C T . . . . No References Variant Details
98 16223 C T . . . . No References Variant Details
99 16230 A G . . . . No References Variant Details
100 16249 T C . . . . No References Variant Details
101 16257 - A . . . . No References Variant Details
102 16264 C - . . . . No References Variant Details
103 16274 G A . . . . No References Variant Details
104 16278 C T . . . . No References Variant Details
105 16284 A G . . . . No References Variant Details
106 16288 T C . . . . No References Variant Details
107 16290 C T . . . . No References Variant Details
108 16293 A C . . . . No References Variant Details
109 16301 C T . . . . No References Variant Details
110 16311 T C . . . . No References Variant Details
111 16355 C T . . . . No References Variant Details
112 16356 T C . . . . No References Variant Details
113 16368 T C . . . . No References Variant Details
114 16369 G T . . . . No References Variant Details
115 16390 G A . . . . No References Variant Details
116 16399 A G . . . . No References Variant Details
117 16444 C T . . . . No References Variant Details
118 16496 G A . . . . No References Variant Details
119 16519 T C . . . . No References Variant Details
120 16527 C T . . . . No References Variant Details
No. Position Ref Alt Gene Symbol Functional Effect MITOMAP Disease Clinical Information MITOMAP Disease Clinical Status References Details